Singapore Mundipharma’s president of Asia Pacific, Latin America, and the Middle East and Africa, Raman Singh defines the underlying drivers behind the company’s explosive growth, while sharing his insights on what it takes for pharma companies to truly succeed in modern-day emerging markets. He also elaborates on Mundipharma’s recent decision to…
Takeda Takeda Mexico’s José Manuel Caamaño discusses Takeda’s impressive growth prospects in Mexico, patient-centricity, the reopening of their cutting-edge manufacturing plant in Naucalpan, and his vision to transform Takeda into one of the most prominent pharmaceutical companies in Mexico, with a strengthened focus on GI and oncology. Christophe Weber, Takeda’s CEO,…
Amgen Established in November 2014, Amgen’s Next-Generation Biomanufacturing facility in Singapore heralds a new juncture of efficient and innovative commercial-scale production of medicines. VP of Singapore Site Operations, Arleen Paulino, pinpoints the elements that distinguish this facility from current standards in manufacturing, while highlighting the key role that this facility will…
CMO Marian Gono, COO, and Marian Takac, VP Sales and Marketing, of Hameln rds discuss the scope of the company’s operations in Slovakia, the key milestone of attaining FDA approval just three years after setting up the facility, and the challenges and opportunities of being based in Slovakia. Could you first…
Manufacturing James Byrne, VP Site for Ipsen Manufacturing Ireland, discusses the strategic importance of the Ireland site as the sole provider of peptides for products generating over 50 percent of Ipsen’s global revenues; his strategy for attracting and retaining the best talent; and his thoughts on the impact of new manufacturing…
Ireland Dr. Paul Downing, General Manager of Hovione’s manufacturing plant in Cork, outlines the successes of the past few years, his emphasis on staff development and training, the CDMO’s advantages of agility and responsiveness, Ireland’s value proposition for the pharma manufacturing industry, and his vision for the next few years. Can…
Ireland Alan MacNeice, Executive Director and Site Leader at Jazz Pharmaceuticals, highlights the strategic importance of the Athlone site as the company’s first purpose-built, directly owned, managed and operated manufacturing facility; the special design of the facility catering to Jazz Pharmaceuticals business model; the importance of their human resource (HR) activities…
Pharma Efrén Ocampo, CEO of the Mexican pharmaceutical group Neolpharma, details the strategic thinking that has fostered the emergence of one of the most prominent healthcare groups in Mexico and the challenges and opportunities that lie ahead in Mexico and abroad. Neolpharma Group encompasses five manufacturing companies and 14 other service…
Ireland Barry Heavey, Head of Life Sciences at IDA Ireland, Ireland’s inward investment promotion agency, discusses IDA’s focus on acting as a catalyst for B2B collaboration in converging industries like connective health solutions and innovative drug delivery devices, their focus on advanced manufacturing, and his mission to make IDA Ireland the…
Pharma Javier Amtmann, the new president of AMIIF, the Mexican association of pharmaceutical innovators, reveals AMIIF’s strategic priorities and key areas of focus. As Chairman of the Board of Menarini Mexico, he also explains how the Italian company successfully entered the Mexican market and continues to increase its market share in…
Pharma Philippe Richert, President of the newly created region Grand Est (Regions Alsace, Champagne-Ardenne and Lorraine) shares the significance of life sciences to his local economy, the industrial heritage which have made the region a leading exporter of pharmaceuticals, as well as the world-class innovation taking place there. Finally, he discusses…
Pharma After a number of years of difficulty post-2008 and the euro-debt crisis, Ireland’s pharma manufacturing industry and economy in general is now firmly on the up. The local Irish pharma market is still under some pressure following years of austerity which saw the average price of a reimbursable medicine cut…
See our Cookie Privacy Policy Here
